BRIEF-Ranbaxy to resume manufacture of generic Lipitor for U.S.
Feb 22 (Reuters) - Ranbaxy Laboratories Ltd : * Says resuming manufacture of generic lipitor for U.S.
- Target holiday cyber breach hits 40 million payment cards
- UPDATE 3-Saab wins Brazil jet deal after NSA spying sours Boeing bid
- Special Report: Why Ukraine spurned the EU and embraced Russia
- Zuckerberg to sell Facebook shares worth about $2.3 billion
- Facebook, Zuckerberg, banks must face IPO lawsuit: judge